HB1529 (2018) Detail

Relative to prescription drug rebate amounts.


HB 1529 - AS INTRODUCED

 

 

2018 SESSION

18-2683

01/03

 

HOUSE BILL 1529

 

AN ACT relative to prescription drug rebate amounts.

 

SPONSORS: Rep. Butler, Carr. 7; Rep. Rosenwald, Hills. 30; Rep. Williams, Hills. 4; Rep. Fothergill, Coos 1; Rep. Knirk, Carr. 3

 

COMMITTEE: Commerce and Consumer Affairs

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill requires the insurance commissioner to select 25 prescription drugs and requires insurance carriers and pharmacy benefit managers to annually disclose the amount rebated from drug manufacturers offering rebate programs during the prior year.  Under this bill, the commissioner shall analyze the information and include it in the annual report required under RSA 420-G:14-a.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

18-2683

01/03

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Eighteen

 

AN ACT relative to prescription drug rebate amounts.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  New Section; Health Care Coverage; Prescription Drug Rebates.  Amend RSA 420-G by inserting after section 14-c the following new section:

420-G:14-d  Prescription Drug Rebate Amounts.  

I.  The commissioner shall select 25 prescription drugs based on high cost and utilization and shall require insurance carriers and pharmacy benefit managers to annually disclose the amount rebated for such drugs from drug manufacturers offering rebate programs during the prior year.  The commissioner shall analyze the findings including, but not limited to, populations served, demographics of those receiving rebates, types of medication and diagnoses impacted, and the cost of medications with and without rebates.

II.  The commissioner shall include the findings in the annual report required under RSA 420-G:14-a.

2  Prescription Drug Rebate Amounts.  Amend RSA 420-G:14-a, VI(b) to read as follows:

(b)  The commissioner shall also include in the report an analysis of the findings under RSA 420-G:14-d.

(c)  The commissioner shall submit the annual report to the governor, the president of the senate, and the speaker of the house of representatives on or before November 1 of each year.

3  Effective Date.  This act shall take effect 60 days after its passage.

Links

HB1529 at GenCourtMobile

Action Dates

Date Body Type
Jan. 17, 2018 House Hearing
Feb. 20, 2018 House Exec Session
House Floor Vote
March 6, 2018 House Floor Vote

Bill Text Revisions

HB1529 Revision: 2129 Date: Nov. 6, 2017, 2:22 p.m.

Docket

Date Status
Jan. 3, 2018 Introduced 01/03/2018 and referred to Commerce and Consumer Affairs HJ 1 P. 14
Jan. 17, 2018 Public Hearing: 01/17/2018 11:15 AM LOB 302
Jan. 30, 2018 Subcommittee Work Session: 01/30/2018 11:15 AM LOB 302
Feb. 20, 2018 Subcommittee Work Session: 02/20/2018 09:30 AM LOB 302
Feb. 21, 2018 Subcommittee Work Session: 02/21/2018 09:30 AM LOB 302
Feb. 20, 2018 Executive Session: 02/20/2018 LOB 302
March 6, 2018 Committee Report: Inexpedient to Legislate for 03/06/2018 (Vote 20-0; CC) HC 9 P. 7
Committee Report: Inexpedient to Legislate (Vote 20-0; CC)
March 6, 2018 Inexpedient to Legislate: MA VV 03/06/2018 HJ 6 P. 11